Company: SXTPW
Filing Date: 2025-09-02
Form Type: DEFR14A
Source: 0001213900-25-082789
Chunk: 50

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-09-02
Form: DEFR14A
Chunk 50
---
 Consequences The par value per share of our common stock will remain unchanged at $0.0001 per share following a Reverse Stock Split. As a result, as of the Effective Date, the stated capital on the our balance sheets attributable to common stock will be reduced proportionally based on the Reverse Stock Split ratio, and the additional paid-in capital will be credited with the amount by which the capital is reduced. The net income or loss per share of common stock will be increased as a result of the fewer shares of common stock outstanding. The Reverse Stock Split will be reflected retroactively in our consolidated financial statements. The Board of Directors recommends a vote “FOR” the approval of the Reverse Stock Split. The Board of Directors retains the discretion to abandon, and not implement, the aforementioned amendments at any time before they become effective. 34 PROPOSAL 4 RATIFICATION OF THE SELECTION OF RBSM LLP AS OUR INDEPENDENT AUDITOR FOR THE FISCAL YEAR ENDING DECEMBER 31, 2024 Proposal: The Board of Directors is asking that you vote to ratify the Board’s selection of RBSM LLP (“RBSM”) as our independent registered public accounting firm for fiscal year 2025. During the year ended December 31, 2024, and 2023, we engaged RBSM LLP as our independent registered public accounting firm. For the years ended December 31, 2024, and 2023, we incurred fees, as discussed below:

|                       |     | Fiscal Year Ended 
 December 31,      |    2024 |     |   |    2023 |
|:----------------------|:----|:------------------|--------:|:----|:--|--------:|
| Audit Fees(1)         |     | $                 | 163,069 |     | $ | 182,000 |
| Audit-Related Fees(2) |     |                   | 135,000 |     |   |  65,000 |
| Tax Fees              |     |                   |       - |     |   |       - |
| All Other Fees        |     |                   |       - |     |   |       - |
| Total                 |     | $                 | 298,069 |     | $ | 247,000 |

| (1) | Audit fees consist of fees relating to the audit of the Company’s                                            
 annual consolidated financial statements and reviews of interim condensed consolidated financial statements. |

| (2)